Screener
Krystal Biotech, Inc. KRYS Pre-Tax Income
Pre-Tax Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except per share data) | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Income from operations | 53,689 | 36,252 |
| Other income | ||
| Interest and other income, net | 7,753 | 7,345 |
| Income before income taxes | 61,442 | 43,597 |
| Income tax expense | (5,510) | (7,864) |
| Net income | 55,932 | 35,733 |
| Unrealized (loss) gain on available-for-sale securities | (1,577) | 344 |
| Foreign currency translation | (1,182) | 236 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s pre-tax income?
- Krystal Biotech, Inc. (KRYS) reported pre-tax income of $61.44M in Q1 2026.
- How has Krystal Biotech, Inc.'s pre-tax income changed year-over-year?
- Krystal Biotech, Inc.'s pre-tax income increased by 40.9% year-over-year, from $43.6M to $61.44M.
- What is the long-term trend for Krystal Biotech, Inc.'s pre-tax income?
- Over 3 years (2021 to 2025), Krystal Biotech, Inc.'s pre-tax income has grown at a 39.6% compound annual growth rate (CAGR), from -$69.57M to $189.47M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.
Ask your AI about Krystal Biotech, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude